PK Partners – CASE CASSIOPEA advised ClinStorage AB Shareholders on Sale to Rubicon Healthcare Partners PK Partners – CASE CASSIOPEA acted as exclusive sell-side financial advisor to the shareholders of ClinStorage AB in connection with the sale of a majority stake to Rubicon Healthcare Partners. ClinStorage AB is a leading Nordic provider of GxP-compliant biostorage, sample management, and related logistics services, supporting pharmaceutical companies, biotechnology firms, contract research organisations (CROs), and research institutions with secure and reliable solutions for the storage and handling of clinical trial materials. Headquartered in Stockholm, Sweden, ClinStorage has established itself as a trusted partner within the life sciences ecosystem by providing regulatory-compliant storage and handling services for clinical research programs, and in addition to temperature-controlled GMP storage, the company offers a range of value-added clinical services including secondary packaging and labelling of investigational products, sourcing of comparator drugs for clinical studies, Qualified Person (QP) oversight, biobanking, and controlled distribution of clinical trial materials to study sites. Rubicon Healthcare Partners will become the company’s new majority owner. ClinStorage will continue to operate under its existing brand, leadership, and operational structure, with the current management team remaining in place and reinvesting in the business. “This partnership enables us to accelerate our growth while staying true to what has made us successful – quality, flexibility and close customer collaboration,” said Jonas Östregård, CEO of ClinStorage AB. “Rubicon’s sector expertise and experience in developing growing healthcare companies make them an ideal partner for us. With their support, we can invest further in infrastructure, expand our services, and continue providing the secure, compliant, and responsive service our customers rely on.” |